Ville Paavilainen

Ville Paavilainen is a Research Director at the Institute of Biotechnology, University of Helsinki, and supervisor for doctoral programs in Biomedicine and Integrative Life Science. With a postdoctoral background at the University of California, San Francisco (2008–2014), he focuses on Biochemistry, Cell Biology, and Molecular Biology, particularly mechanisms of protein translocation, membrane biology, and structural modeling.

His research includes groundbreaking work on Sec61 translocon inhibition for cancer therapy and mitochondrial gene expression noise. Recent publications address lipid scrambling pathways, glioma stem cell targeting, and actin regulation. Active projects span EU-funded drug discovery and NIH collaborations.

Key scientific contributions include

• Elucidating Sec61-client interactions
• Developing computational models for signal peptide prediction
• Uncovering mitochondrial-ER communication mechanisms

He has supervised PhD theses (e.g., Paul Carlson) and contributed to over 39 research outputs. His work bridges structural biology, computational modeling, and translational pharmacology, with applications in tumor biology and neurodegenerative disease research.